Navigation Links
Stipkala LLC to Sponsor Texas Life Science Conference November 12-13, 2009
Date:11/9/2009

HOUSTON, Nov. 9 /PRNewswire/ -- Patent attorneys Cheryl Liljestrand, Ph.D, J.D., and Jeremy M. Stipkala, Ph.D., J. D., will showcase Stipkala LLC at the Texas Life Science Conference November 12-13, 2009, which will be held at the Institute of Molecular Medicine in Houston, TX. The Texas Life Science Conference provides a platform for cutting-edge companies to introduce their growth opportunities to investors, and will feature keynote addresses and panel discussions on industry perspectives, viable business models, cash management, alternative financing, and other useful topics. Also, receptions and dine-arounds will offer ample networking opportunities for national and local venture capitalists, biotechnology entrepreneurs, and service providers.

The Texas Life Science Conference will highlight some of the state's leading biotechnology enterprises. Companies that headquarter in Texas or have a primary technology licensed from a Texas research university are encouraged to attend. For more information about the conference, or to register online, please visit: http://www.texaslifescienceconference.com/index.html.

Dr. Liljestrand specializes in patenting biotechnology, immunology, pharmaceutical, and biologic innovations from her office in Pearland, TX. Dr. Stipkala focuses on chemical and pharmaceutical inventions, among others. Stipkala LLC, a premier nationwide intellectual property law firm, proudly supports the Conference as a Gold Sponsor, and will give each attendee a special gift. For more information about Stipkala LLC, please visit: www.StipkalaLaw.com.

SOURCE Stipkala LLC


'/>"/>
SOURCE Stipkala LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
2. Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
3. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
4. ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
5. Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R)
6. Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
7. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
8. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
9. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
10. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
11. MedNet Solutions to Sponsor and Exhibit at the 2008 Advanced Medical Technology Association Conference in Washington, D.C.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Integrated Silicon Solution, Inc. (Nasdaq: ... IC solutions, today announced that it will host its ... 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) to ... third quarter ended June 30, 2014. To ... 6:50 a.m. Pacific time on July 24, 2014.  The ...
(Date:7/10/2014)... Ariz. , July 10, 2014   Ventana ...  Group, today announced it has entered into an agreement ... which operates as EMD Serono in the ... , to collaborate with Merck KGaA,s biopharmaceutical division on ... for an undisclosed target using Ventana,s proprietary diagnostic assays. ...
(Date:1/15/2014)... MILTON, N.Y. , Jan. 15, 2014 Sono-Tek Corporation ... three months ended November 30, 2013, compared to sales of ... or 20%. Once again, this quarter has also shown growth ... in the first quarter of this fiscal year. Markets that ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4
(Date:7/10/2014)... -- Most professional football players who have shoulder stabilization ... new study finds. Shoulder instability is a common ... after surgery to fix the problem has been unclear, ... 60 players who had shoulder stabilization surgery. Ninety percent ... play, defined as playing in at least one regular ...
(Date:7/10/2014)... who have a vasectomy may be at increased risk ... But the risk is comparatively small, the researchers acknowledged. ... more research is needed to determine if the study ... researchers analyzed data from more than 49,400 American men ... During that time, 6,023 cases of prostate cancer were ...
(Date:7/10/2014)... better prepared to respond to an active shooter incident ... study in the journal Prehospital and Disaster Medicine ... the EMS provider comfort level with respect to entering ... neutralized or working with law enforcement personnel during that ... shooting, the Virginia Tech campus shooting, the 2009 Fort ...
(Date:7/10/2014)... health concerns in the United States, with 32 percent ... 2012. As health problems such as childhood obesity grow, ... the problem. , A new study, led by Jenine ... at Washington University in St. Louis, examined the use ... conversations about the issue of overweight kids. , The ...
(Date:7/10/2014)... Up to 70% of Parkinson,s disease (PD) patients ... of life. Some patients have disturbed sleep/wake patterns ... while other patients may be subject to sudden ... PD patients may exhibit REM-sleep behavior disorder (RBD), ... even before motor symptoms appear. A review in ...
Breaking Medicine News(10 mins):Health News:Shoulder Surgery Gets NFL Players Back in the Game 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 3Health News:Active shooter training increases comfort level of emergency responders 2Health News:Study looks at how Twitter can be used to address specific health issues 2Health News:Sleep disturbances, common in Parkinson's disease, can be early indicator of disease onset 2
... is a serious complication that can occur in children ... lead to heart attack, pulmonary embolism and other cardiovascular ... research performed in Italy by the Laboratory of Genetic ... Catholic University in collaboration with the Haematology Division of ...
... Philadelphia have discovered a second gene that causes Alagille ... affects many organs.// , This finding may have ... Children's Hospital team had earlier discovered the first gene ... that mutations in the NOTCH 2 gene were linked ...
... solid food to infants less than six months old is ... food allergies later and new moms should rather breastfeed them ... be avoided for the first six months, and certain items ... introduced until even later, according to the American College of ...
... Danish residents revealed that a specific mutation in the CHEK2 ... cancer in her lifetime. The study, which was the first ... cancer risk associated with it, in the general population, will ... of Clinical Oncology. ,"Our study shows that ...
... compounds in cocoa could improve blood circulation, according ... flow// in menopausal women with high cholesterol.,'The totality ... new insights into how cocoa flavanols may improve ... known,' said Harold Schmitz, PhD, Chief Science Officer ...
... the University of Georgia have suggested that cross-immunity created ... strain protect against infection //,by related serotypes thus leading ... This finding would help understand the pattern of ... since about the mid 1980s, there's been a sequential ...
Cached Medicine News:Health News:Thrombosis, a Serious Risk in Children with Leukemia 2Health News:Second Alagille Syndrome Gene discovered: More information on kidney disease 2Health News:CHEK 2 Gene Mutation Triples Breast Cancer Risk 2Health News:Waxing And Waning Of Dengue Epidemics Attributed To Cross-Immunity 2Health News:Waxing And Waning Of Dengue Epidemics Attributed To Cross-Immunity 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: